EUVIMEDEUVIMED entdecken
Crossref

Evolution of 8-esterified cycloberberines as a novel class of antibacterial agents against MDR gram-positive strains by targeting DNA polymerase IIIC

Tianyun Fan, Liping Zhao, Xican Ma, Jia Tang, Qionglu Duan, Xi Zhu, Yonghua Liu, Jiandong Jiang, Yinghong Li, Danqing Song

Bioorganic Chemistry · 2025

DOI: 10.1016/j.bioorg.2025.108640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Tianyun Fan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical Co…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Berberine, Gram-Positive Bacteria, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences and Peking Union Medical College, National Natural Science Foundation of China, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The constant evolution of Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant S. aureus (VRSA) constitutes a major threat to human health with limited treatment options. In our previous studies, we invented an innovative cycloberberine (CBBR) scaffold to battle MRSA and other Gram-positive strains. Herein, we report the synthesis and biological evaluations of forty-four CBBR esters derivatives, of which forty-two were new, against Gram-positive pathogens. Compound 5a demonstrated superior in vitro potency against MRSA and VISA strains, with MIC values of 0.06-0.125 μg/mL, outperforming the reference drug levofloxacin (MIC range: 0.125-32 μg/mL). Meanwhile, it reduced the MRSA burden in murine skin infection model and decreased pro-inflammatory cytokine levels, exemplified as interleukin (IL)-1β and IL-6, in MRSA-infected wounds. Further mechanism study revealed its unique ability to inhibit bacterial genomic DNA replication by targeting DNA polymerase IIIC, distinct from the clinical antibiotics. Therefore, we consider CBBR ester derivatives to be a promising class of anti-MRSA agents worthy of further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBerberineGram-Positive BacteriaMethicillin-Resistant Staphylococcus aureusAnimalsHumansMiceDose-Response Relationship, DrugDrug Resistance, Multiple, BacterialInterleukinsMicrobial Sensitivity TestsMolecular StructureStructure-Activity Relationship

Stichwörter der Autor:innen

Antibacterial activityCycloberberine esterDNA polymerase IIICMRSAStructure-activity relationship

Substanzen

Anti-Bacterial AgentsBerberineInterleukins

Autor:innen und Institutionen

  • Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. Electronic address: liyinghong@imb.pumc.…
  • Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. Electronic address: songdanqing@imb.pumc…

Förderung

  • Chinese Academy of Medical Sciences and Peking Union Medical College
  • National Natural Science Foundation of China
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Zitieren

APA

Fan, T., Zhao, L., Ma, X., Tang, J., Duan, Q., Zhu, X., Liu, Y., Jiang, J., Li, Y., & Song, D. (2025). Evolution of 8-esterified cycloberberines as a novel class of antibacterial agents against MDR gram-positive strains by targeting DNA polymerase IIIC. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108640

Vancouver

Fan T, Zhao L, Ma X, Tang J, Duan Q, Zhu X, et al. Evolution of 8-esterified cycloberberines as a novel class of antibacterial agents against MDR gram-positive strains by targeting DNA polymerase IIIC. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108640

BibTeX
@article{Fan2025,
  author = {Fan, Tianyun and Zhao, Liping and Ma, Xican and Tang, Jia and Duan, Qionglu and Zhu, Xi and Liu, Yonghua and Jiang, Jiandong and Li, Yinghong and Song, Danqing},
  title = {Evolution of 8-esterified cycloberberines as a novel class of antibacterial agents against MDR gram-positive strains by targeting DNA polymerase IIIC},
  journal = {Bioorganic Chemistry},
  year = {2025},
  doi = {10.1016/j.bioorg.2025.108640}
}
Kostenlos starten →